Print

IMPAX Laboratories, Inc. (IPXL) Launches Oxymorphone Hydrochloride Extended-Release Tablets  
1/4/2013 10:13:22 AM

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it is commencing shipment of Oxymorphone Hydrochloride Extended-Release Tablets, through Global Pharmaceuticals, Impax’s generics division.
//-->